Dry Eye clinical trials at UC Cancer

1 research study open to eligible people

Showing trials for

  • Azithromycin for Meibomian Gland Disease

    open to eligible people ages 18 years and up

    This study aims to elucidate the effectiveness of oral azithromycin in treating symptomatic dry eye syndrome secondary to Meibomian gland dysfunction.

    at UCSF

Our lead scientists for Dry Eye research studies include .

Last updated: